ANI Pharmaceuticals, Inc. (BST:BSFA)

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,445	1,043	952	614	678	285
Market Cap Growth	32.53%	9.52%	55.11%	-9.53%	138.20%	-56.40%
Enterprise Value	1,750	1,529	1,063	855	850	437
Last Close Price	69.00	51.00	48.60	37.60	40.80	22.40
PE Ratio	49.65	-	68.00	-	-	-
PS Ratio	2.05	1.76	2.16	2.07	3.57	1.67
PB Ratio	3.35	2.52	2.30	1.94	2.15	1.78
P/TBV Ratio	-	-	5.38	19.39	64.94	96.52
P/FCF Ratio	10.89	22.59	9.56	-	1008.43	38.15
P/OCF Ratio	9.93	16.86	8.85	-	232.23	22.82
EV/Sales Ratio	2.50	2.58	2.41	2.89	4.47	2.57
EV/EBITDA Ratio	14.24	19.23	10.75	26.93	50.64	18.40
EV/EBIT Ratio	40.46	108.31	23.73	-	-	-
EV/FCF Ratio	13.19	33.14	10.67	-	1263.31	58.56
Debt / Equity Ratio	1.25	1.47	0.62	0.85	0.80	1.02
Debt / EBITDA Ratio	4.36	7.44	2.61	8.26	15.06	6.87
Debt / FCF Ratio	4.06	13.20	2.60	-	375.65	21.88
Asset Turnover	0.61	0.56	0.59	0.41	0.35	0.45
Inventory Turnover	2.20	2.02	1.68	1.48	1.41	1.60
Quick Ratio	1.94	1.93	2.63	2.15	2.61	1.32
Current Ratio	2.58	2.73	3.57	3.46	3.68	2.17
Return on Equity (ROE)	8.66%	-4.18%	4.72%	-13.74%	-15.37%	-11.04%
Return on Assets (ROA)	2.37%	0.83%	3.72%	-2.10%	-2.86%	-2.12%
Return on Invested Capital (ROIC)	4.73%	2.04%	8.51%	-4.58%	-6.04%	-4.26%
Return on Capital Employed (ROCE)	4.50%	1.30%	6.50%	-3.90%	-4.10%	-4.10%
Earnings Yield	2.01%	-1.72%	1.79%	-7.30%	-5.52%	-6.47%
FCF Yield	9.19%	4.43%	10.46%	-6.11%	0.10%	2.62%
Payout Ratio	3.85%	-	8.65%	-	-	-
Buyback Yield / Dilution	-6.95%	-6.18%	-11.89%	-29.09%	-5.28%	0.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.